DEPARTMENT CF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES CF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
WORKING GROUP ON BIOTECHNOLOGY COORDINATION 
MINUTES OF MEETING 1 
March 1, 1985 
The Working Group on Biotechnology Coordination of the Recombinant ENA Advisory 
Carmittee was convened at 9:00 a.m. on March 1, 1985, at the National Institutes 
of Health, 9000 Rockville Pike, Bethesda, Maryland 20205. Mr. Robert Mitchell 
was the Chair. The following people were present for all or part of the meeting 
Working Group members: 
Roys ton Clowes 
David Friedman 
Susan Gottesman 
Arthur Lardy 
Myron Levine 
Gerard McGarrity 
Robert McKinney 
Robert Mitchell 
Thomas Pirone 
LeRoy Waiters 
William Gartland, Jr. 
(Executive Secretary) 
A working group roster is attached (Attachment I). 
Other National Institutes of Health staff: 
Elizabeth Milewski, NIAID 
Others: 
Carter Blakey, Federation of American Societies for Experimental Biology 
Irene Brandt, Eli Lilly and Company 
Jeff Christy, Blue Sheet, FTC Reports, Inc. 
Marie Dray, Pharmaceutical Manufacturers Association 
Peter Farnham, American Society of Biological Chemists 
Joseph R. Fbrdham, Nova Laboratories, Inc. 
David J. Glass, BioTechnica International, Inc. 
Alan Goldhanmer, Industrial Biotechnology Association 
Michael Gross, Triton Biosciences, Inc. 
John H. Keene, Abbott Laboratories 
Henry Miller, Pood and Drug Administration 
Carole Sherman 
Paul Stem, University of Florida 
William Walsh, Department of State 
Judith Wortman, American Institute of Biological Sciences 
lr The working group is advisory to the RAC, and its recommendations should not 
be considered as final or accepted. 
[ 331 ] 
